Long-term Mechanical Circulatory Support Market

Long-term mechanical circulatory support (LT-MCS) is an important treatment modality for patients with severe heart failure.

Long-term Mechanical Circulatory Support Market contains market size and forecasts of Long-term Mechanical Circulatory Support (LT-MCS) in global, including the following market information:

• Global Long-term Mechanical Circulatory Support (LT-MCS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Long-term Mechanical Circulatory Support (LT-MCS) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Long-term Mechanical Circulatory Support (LT-MCS) companies in 2021 (%)

The global Long-term Mechanical Circulatory Support (LT-MCS) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Extracorporeal Membrane Oxygenation Device Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Long-term Mechanical Circulatory Support (LT-MCS) include Abbott Laboratories, LivaNova, Nipro Corporation, Terumo Corporation, Medtronic, BiVACOR, Evaheart and Abiomed, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Long-term Mechanical Circulatory Support (LT-MCS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Long-term Mechanical Circulatory Support (LT-MCS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Long-term Mechanical Circulatory Support (LT-MCS) Market Segment Percentages, by Type, 2021 (%)

• Extracorporeal Membrane Oxygenation Device
• Extracorporeal Ventricular Assist Device
• Others

Global Long-term Mechanical Circulatory Support (LT-MCS) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Long-term Mechanical Circulatory Support (LT-MCS) Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Specialized Cardiac Centers
• Ambulatory Surgery centers
• Others

Global Long-term Mechanical Circulatory Support (LT-MCS) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Long-term Mechanical Circulatory Support (LT-MCS) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa
• Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Long-term Mechanical Circulatory Support (LT-MCS) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Long-term Mechanical Circulatory Support (LT-MCS) revenues share in global market, 2021 (%)
• Key companies Long-term Mechanical Circulatory Support (LT-MCS) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Long-term Mechanical Circulatory Support (LT-MCS) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbott Laboratories
• LivaNova
• Nipro Corporation
• Terumo Corporation
• Medtronic
• BiVACOR
• Evaheart
• Abiomed